Profile cover photo
Profile photo
Komunitas Farmasi
153 followers -
Komunitas Farmasi di Google+! Bergabung dan Berbagi Bersama Kami!
Komunitas Farmasi di Google+! Bergabung dan Berbagi Bersama Kami!

153 followers
About
Posts

Post has attachment
CDC officials reported Monday that influenza activity is widespread in 43 states, up from 36 states in the previous week. The report noted that there have been 21 flu-related deaths already this season, including six children in the last full week of…
Add a comment...

Post has attachment
CDC officials reported Monday that influenza activity is widespread in 43 states, up from 36 states in the previous week. The report noted that there have been 21 flu-related deaths already this season, including six children in the last full week of…
Add a comment...

Post has attachment
Pharmacogenomics is possible, but not a reality yet. That’s the opinion of many experts in the field right now who see it as a service pharmacists should be aligned with, particularly within medication therapy management (MTM). A study published in the…
Add a comment...

Post has attachment
Pharmacogenomics is possible, but not a reality yet. That’s the opinion of many experts in the field right now who see it as a service pharmacists should be aligned with, particularly within medication therapy management (MTM). A study published in the…
Add a comment...

Post has attachment
FDA regulators are warning consumers about the risks of so-called “miracle” weight loss supplements and foods. FDA regulators are warning consumers about the risks of so-called “miracle” weight loss supplements and foods. According to the agency, hundreds…
Add a comment...

Post has attachment
January 06, 2015 CVS Health Corp. says it will make Gilead’s drugs ledipasvir sofosbuvir (Harvoni) and sofosbuvir (Sovaldi) the exclusive option for patients on its commercial drug list, as well as for patients it manages on health care exchanges,…
Add a comment...

Post has attachment
January 06, 2015 FDA reviewers recommended on Monday approval for Novartis’ biosimilar version of Amgen’s cancer drug filgrastim (Neupogen). Novartis’ Zarzio is the first drug to be reviewed in the United States under the biosimilar pathway. FDA reviewers…
Add a comment...

Post has attachment
FDA regulators are warning consumers about the risks of so-called “miracle” weight loss supplements and foods. FDA regulators are warning consumers about the risks of so-called “miracle” weight loss supplements and foods. According to the agency, hundreds…
Add a comment...

Post has attachment
By maximizing the role of pharmacists, opportunities often exist to improve medication adherence and care for patients with hypertension and diabetes. The APhA Foundation and CDC’s Division for Heart Disease and Stroke Prevention (DHDSP) are partnering on…
Add a comment...

Post has attachment
January 06, 2015 CVS Health Corp. says it will make Gilead’s drugs ledipasvir sofosbuvir (Harvoni) and sofosbuvir (Sovaldi) the exclusive option for patients on its commercial drug list, as well as for patients it manages on health care exchanges,…
Add a comment...
Wait while more posts are being loaded